Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of eutectic of 5-fluorouracil and kaempferol and preparation method thereof

A technology of fluorouracil and kaempferol, which is applied in the field of medicinal chemistry, can solve the problems of poor solubility of kaempferol, low oral bioavailability, and limited potential of active anti-tumor drugs, and achieve good reproducibility, easy control of the crystallization process, and improved preparations compatibility effect

Active Publication Date: 2021-09-03
TIANJIN UNIVERSITY OF TECHNOLOGY +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite its outstanding antitumor activity, kaempferol has low oral bioavailability due to its very poor solubility, limiting its potential as an active antitumor drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of eutectic of 5-fluorouracil and kaempferol and preparation method thereof
  • A kind of eutectic of 5-fluorouracil and kaempferol and preparation method thereof
  • A kind of eutectic of 5-fluorouracil and kaempferol and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Weigh 1.30 g of 5-fluorouracil and 2.86 g of kaempferol, add 30 ml of absolute ethanol to obtain a suspension, stir the suspension at room temperature for 5 hours, filter, and dry the resulting white solid at 40°C to obtain 5- A solid sample of co-crystal of fluorouracil and kaempferol, the yield is 83.3%.

Embodiment 2

[0048] Weigh 32.5 mg of 5-fluorouracil and 71.6 mg of kaempferol, add 1 ml of methyl acetate to obtain a suspension, stir the suspension at room temperature for 12 hours, filter, and dry the obtained white solid at 40°C to obtain 5- Solid sample of co-crystal of fluorouracil and kaempferol.

Embodiment 3

[0050] Weigh 13.0 mg of 5-fluorouracil and 28.6 mg of kaempferol, add them to a ball mill jar, then add 20 microliters of ethyl acetate, grind at a frequency of 20 Hz for 60 minutes, and dry the resulting white solid at 40°C to obtain 5-fluorouracil and kaempferol Eutectic solid samples.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
densityaaaaaaaaaa
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a co-crystal of 5-fluorouracil and kaempferol and a preparation method thereof. The molar ratio of 5-fluorouracil and kaempferol in the eutectic is 1:1, and the X-ray powder diffraction pattern of the eutectic is 12.2±0.2°, 13.9±0.2°, 14.8±0.2°, 16.5±0.2°, There are characteristic peaks at 17.5±0.2° and 26.7±0.2°. The eutectic preparation method provided by the invention has simple process, easy control of the crystallization process, good reproducibility, and is suitable for industrial production. This co-crystal can effectively reduce the hygroscopicity of kaempferol, optimize the dissolution properties of 5-fluorouracil and kaempferol, reduce the difference in solubility between the two, improve the compatibility of the preparations of the two drugs, and provide better performance for the two drugs. Anti-tumor synergy provides a research basis.

Description

technical field [0001] The invention relates to the technical field of medicinal chemistry, in particular to a co-crystal of 5-fluorouracil and kaempferol and a preparation method thereof. Background technique [0002] Pharmaceutical active ingredients usually exist in crystalline forms, such as polymorphs, hydrates, solvates, salts, and co-crystals. Pharmaceutical co-crystals refer to crystalline substances in which active pharmaceutical ingredients and co-crystal formers are combined in the same crystal lattice in a fixed stoichiometric ratio through non-covalent interactions. The formation of co-crystals can adjust the physicochemical properties of drugs, including solubility, dissolution rate, bioavailability, stability, tabletability, etc., without changing the chemical structure. The co-crystal formed by the active ingredients of two drugs is also called drug-drug co-crystal, which can not only improve the physical and chemical properties of the two drugs at the same ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D239/553C07D311/30A61P35/00A61K31/513A61K31/352
CPCA61P35/00C07B2200/13C07D239/553C07D311/30
Inventor 陈嘉媚吕文婷庄晓梅
Owner TIANJIN UNIVERSITY OF TECHNOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com